Achillion Pharmaceuticals Inc Archives

MERCK TO PAY $3.85B FOR HEPATITIS C DRUG DEVELOPER

By LINDA A. JOHNSON FILE – This Thursday, Feb. 28, 2013 file photo shows a patch with the Merck logo on a scientist’s lab coat in West Point, Pa. Merck…

Tagged: Achillion Pharmaceuticals Inc, Business, Cascade Media Group, CMG, Corporate news, Corporate stock, Diagnosis and treatment, Diseases and conditions, Drug approvals, Gilead Sciences Inc, Government and politics, Health & Wellness, Health care industry, Hepatitis, Idenix Pharmaceuticals Inc, Industries, Infectious diseases, Instagram@ cascademediagroup, Johnson & Johnson, Liver disease, Medication, Merck & Co Inc, Mergers and acquisitions, New Jersey, New products and services, North America, Ownership changes, Pharmaceutical manufacturing, Product approvals, Products and services, Stock performance, Stock price movements, twitter @whatsupkansascity, U.S. Department of Health and Human Services, U.S. Food and Drug Administration, United States, United States government, www.61a.162.myftpupload.com

Achillion Pharmaceuticals Inc

MERCK TO PAY $3.85B FOR HEPATITIS C DRUG DEVELOPER